New heart scan tracer could make diagnosis easier
NCT ID NCT05625490
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-phase study tested a new radioactive tracer called Ga-68 Galmydar for PET scans of the heart. The goal was to see if it can accurately show blood flow to the heart muscle in people with or without coronary artery disease. Fifteen adults received the tracer and underwent imaging, with results compared to a standard tracer. The study aims to develop a more convenient option for heart imaging.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ga-68 Galmydar (a radioactive tracer for PET scans)
What this could lead to
If successful, this could lead to a more accessible PET tracer for diagnosing coronary artery disease, potentially replacing tracers that require a nearby cyclotron.
What could go wrong
This is a very early, small study (15 participants) focused on imaging feasibility, not treatment. The tracer may not prove superior to existing methods or may have safety issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States